Heart. Published Online First: 3 November 2006. doi:10.1136/hrt.2006.099242
Original articles |
Fetal ECG: A Novel Predictor of Atrioventricular Block in Anti-Ro Positive Pregnancies
1 Imperial College, London, United Kingdom
2 Queen Charlotte's and Chelsea Hospital, London, United Kingdom
3 Royal Brompton Hospital, London, United Kingdom
4 QinetiQ, United Kingdom
* To whom correspondence should be addressed. E-mail: helena.gardiner{at}imperial.ac.uk.
Accepted 3 October 2006
Abstract
Objective Approximately 2.8% of pregnancies are Ro /La antibody positive. Three to 15% fetuses develop complete heart block (CHB). First degree atrioventricular heart block (10 AVB) is reported in a third of Ro/La fetuses but as most have normal postnatal ECG may reflect inadequacies of Doppler measurement techniques.
Design We compared mechanical (mPR) and electrical (ePR) intervals obtained prospectively using Doppler and non-invasive fetal ECG (fECG) in 52 consecutive Ro/La pregnancies in 46 women carrying 54 fetuses in an observational study.
Setting Fetal Medicine Unit
Methods & results We recorded 121 mPR and 37 ePR intervals in 49 Ro/La fetuses. Five were referred with CHB and excluded. ePR was measured successfully in 35/ 37 (94%) and mPR in all. 10 AVB was defined as PR > 95% CI. Logistic regression predicted abnormal final fetal rhythm from first mPR or ePR. ePR model gave 66.7% sensitivity (6 of 8 final abnormal fetal rhythm cases predicted correctly in fetuses >20 weeks) and 96.2% specificity and mPR 44.4% sensitivity (4 of 9 cases) and 88.5% specificity. Z scores for ePR (zPR) were calculated from 199 normal fetuses. Area under ROC curve was 0.88 (95% CI 0.754,1.007). A cut-off of 1.65 gave sensitivity of 87.5% and specificity of 95% for those with prolonged and normal ePR intervals respectively.
Conclusions zPR is better than mPR in differentiating between normal and prolonged PR interval suggesting fECG is the diagnostic tool of choice to investigate the natural history and therapy of conduction abnormalities in Ro/La pregnancies.
Keywords: PR interval, anti-Ro antibodies, complete heart block, fetal ECG, first degree heart block
This article has been cited by other articles:
-
Rein, A.J.J.T., Mevorach, D., Perles, Z., Gavri, S., Nadjari, M., Nir, A., Elchalal, U.
(2009). Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies: A Prospective, Observational, Fetal Kinetocardiogram-Based Study. Circulation
119: 1867-1872
[Abstract] [Full Text] -
Friedman, D. M., Kim, M. Y., Copel, J. A., Davis, C., Phoon, C. K.L., Glickstein, J. S., Buyon, J. P., for the PRIDE Investigators,
(2008). Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study. Circulation
117: 485-493
[Abstract] [Full Text] -
Hornberger, L. K., Collins, K.
(2008). New insights into fetal atrioventricular block using fetal magnetocardiography.. J Am Coll Cardiol
51: 85-86
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
